Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOA-07 adult medulloblastoma pilot study
2007-002560-10Phase 2Completed
- Sponsor
- Free State of Bavaria
- Start
- Aug 2009
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, lomustine and vincristine in medulloblastoma, sponsored by Free State of Bavaria. Primary endpoints: Feasibility of adjuvant chemotherapy and Treatment interruptions due to toxicity. Started Aug 2009; status: completed.
02
Drugs
cisplatinlomustinevincristine
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on 2007-002560-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002560-10.